Quinidine – an established inhibitor of SQTS mutant hERG channels (Gaita et al., 2004; Hu et al., 2017) has shown some efficacy in the ventricles in non-hERG-linked SQTS (e.g., Giustetto et al., 2011). The gene discussed is KCNH2; the disease is Familial short QT syndrome.